How much revenue does MultiCell Technologies make?

MultiCell Technologies reported $49,318 in revenue for fiscal year 2014, about flat from $49,318 in fiscal year 2013. In Q3 2015 revenue was $194,772.

What companies are similar to MultiCell Technologies?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Instadose Pharma Corp. (INSD), BellRock Brands Inc. (DXBRF), Kali, Inc. (KALY), Creative Edge Nutrition, Inc. (FITX).

MultiCell Technologies, Inc. (MCET) Stock

About MultiCell Technologies, Inc.

MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclin...

At a glance

MultiCell Technologies reported revenue of $49,318 for fiscal year 2014, about flat from fiscal year 2013, and net income of -$380,071. In Q3 2015 (the quarter ended August 31, 2015) revenue was $194,772, up 1479.8% from a year before.

Figures from company filings; latest fiscal year ended November 30, 2014.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.